跳至主要内容
临床试验/JPRN-UMIN000013388
JPRN-UMIN000013388招募中未知

Investigation of interindividual factors in erlotinib and its metabolites pharmacokinetics, clinical responses and adverse reactions in Japanese non-small cell lung cancer patients receiving oral erlotinib. - Investigation of interindividual factors in erlotinib and its metabolites pharmacokinetics, clinical responses and adverse reactions in Japanese non-small cell lung cancer patients receiving oral erlotinib.

Department of Hospital Pharmacy Hamamatsu University School of Medicime0 个研究点目标入组 50 人开始时间: 2014年3月12日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients discontinued receiving treatment of oral erlotinib 2. Patients having severe kidney dysfunction or liver dysfunction 3. Patients who are judged by physicians as inappropriate for study enrollment

研究者

发起方
Department of Hospital Pharmacy Hamamatsu University School of Medicime

相似试验